Lundbeck's cost-saving reorg plan to claim up to 200 jobs

The Danish drugmaker Lundbeck unveiled details of its 500-million-kroner cost-savings program. At least a few details, that is. The company said a revamp of its business services operations--which will consolidate in Poland--will hit 180 to 200 jobs over the next two years. Supply-chain simplification and new procurement processes are also part of the plan. Release

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.